Furthermore, P-TEFb promotes enhancer-driven transcription of MYC and MCL1 oncogenes and protein stability of MYC to underwrite cancer cell dependency on these short-lived oncogenic proteins (38–40). The gene discussed is MYC; the disease is cancer.